Betsson AB
STO:BETS B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Betsson AB
STO:BETS B
|
SE |
|
A
|
Akebia Therapeutics Inc
F:AX9
|
US |
|
M
|
MRC Global Inc
XBER:37M
|
US |
|
Graincorp Ltd
ASX:GNC
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BETS B's stock price target?
Not Available
BETS B does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Betsson AB?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Betsson AB?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Betsson AB?
Projected CAGR
-8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is -8%.
What is the Pre-Tax Income forecast for Betsson AB?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is -5%.
What is the Net Income forecast for Betsson AB?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is -2%.
